Value through Innovation27 July 2016

Clinical Study Results

  • CATAPRESAN ® - Healthy
    Clinical Study Number 253.2486
    Study Indication Healthy
    Product CATAPRESAN ®
    Generic Name Clonidine
    Lab Code
    Clinical Phase I
    Study Title

    A randomised, double-blind study designed to assess the bioequivalence and adhesion properties of transdermal clonidine-VistanexTM compared to transdermal clonidine-Oppanol® following transdermal administration in healthy male and female volunteers

    Study Document Trial synopsis 253.2486 english

Clinical Trial Registry and structured study results. Find here protocol information for all clinical study types.

European Trial Register of EU studies.